Cochrane Abstracts
Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Topical Pharmacologic Interventions Versus Placebo for Epidemic Keratoconjunctivitis." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431294/all/Topical_pharmacologic_interventions_versus_placebo_for_epidemic_keratoconjunctivitis.
Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431294/all/Topical_pharmacologic_interventions_versus_placebo_for_epidemic_keratoconjunctivitis. Accessed December 21, 2024.
Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431294/all/Topical_pharmacologic_interventions_versus_placebo_for_epidemic_keratoconjunctivitis
Topical Pharmacologic Interventions Versus Placebo for Epidemic Keratoconjunctivitis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431294/all/Topical_pharmacologic_interventions_versus_placebo_for_epidemic_keratoconjunctivitis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis
ID - 431294
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431294/all/Topical_pharmacologic_interventions_versus_placebo_for_epidemic_keratoconjunctivitis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
